GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

TrivarX TRI.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.01

-9.09%

Close of 6 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

TrivarX — daily ASX:TRI

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View TrivarX on TradingView ↗
Market value
A$11.5m
Last close × shares
Volume
1.4m
Shares, 6 Nov 2026

About TrivarX

Its shares trade on ASX under the ticker TRI.AX. It has been listed since 29 January 2001. In the fiscal year to 30 June 2025, it reported revenue of A$1.1m and a net loss of A$943,231. At that date it held total assets of A$13.5m and shareholders' equity of A$12.7m.

TrivarX Ltd is a AU-based company operating in Health Care Technology industry. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology company engaged in the use of objective measures to aid in the early detection and screening of mental health conditions. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is conducting clinical research, product development and early-stage commercialization of a mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. The company has launched its consumer mobile application to help measure, monitor, and manage stress, called LUCA. LUCA is a biometric assessment tool that measures sleep stress, activity stress, and cardiac stress that allows consumers to monitor their daily stress levels through their own personal wearable device.

Figures and description from our data supplier, not checked against the company's own report.

More about TrivarX →

Latest on TrivarX

Our reporting

We have not reported on TrivarX yet.

Next results

19 Feb 2027

Due on 19 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is TrivarX's ticker?

TrivarX trades as TRI.AX on ASX, under ISIN AU0000300196.

What was TrivarX's last closing price?

0.01 on 6 Nov 2026. The figure is in AUD and is never converted.

When does TrivarX next report results?

Results are expected on 19 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.